USX:VTGN - Vistagen Therapeutics Inc VistaGen Therapeutics Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 26 Jun 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

USD 3.32    +0.09 (+2.79%)

25 Jun 2024


Loading...
Loading...
Loading...

General

CEO: Mr. Shawn K. Singh J.D.

IPO: 2016-05-06

Headquarters: US

Employees: 32

Homepage

Description

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T1

About · FAQs · StocksCafe © 2024 · Privacy · Terms